Skip to Main Content

Lieping Chen, MD, PhD

United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology)



Dr. Lieping Chen is a physician-scientist interested in basic T cell biology, cancer immunology and development of innovative medicine for treating human diseases including cancer. Prior to joining Yale, he was a research scientist in cancer and immunology discovery group in Bristol-Myers Squibb/Oncogen in Seattle, Washington (1989-1997), Professor of Immunology in Mayo Clinic, Rochester, Minnesota (1997-2004) and Professor of Oncology and Dermatology at Johns Hopkins University School of Medicine, Baltimore, Maryland (2004-2021).

Dr. Chen has published over 370 peer-reviewed research articles. His work in discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the years by Science magazine 2013. He is member of the National Academy of Sciences and Fellow of the American Association for Cancer Research.

Education & Training

  • PhD
    Drexel University, Pathology and Laboratory Medicine (1989)
  • MS
    Beijing Union Medical College, Immunology (1986)
  • MD
    Fujian Medical College (1982)

Honors & Recognition

AwardAwarding OrganizationDate
FellowSociety for Immunotherapy of Cancer2021
MemberU.S. National Academy of Sciences2021
FellowAmerican Association for Cancer Research2021
Richard V. Smalley MD Memorial AwardSociety for Immunotherapy of Cancer2020
William O. Russell Lectureship and Joanne Vandenberge Hill AwardUniversity of Texas M.D. Anderson Cancer Center2019
Kurt Hellman AwardMetastasis Research Society2018
Luminary AwardWorld Affairs Council of Connecticut2018
AcademicianAcademia Sinica2018
Giants of Cancer CareOncLive2018
Shizhang Bei AwardBiophysical Society of China2017
Warren Alpert Foundation PrizeWarren Alpert Foundation2017
AAI-Steinman AwardAmerican Association of Immunologists2016
William B. Coley AwardCancer Research Institute2014

Departments & Organizations